Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
ViraferonPeg 120microgram inj pre-filled pens
0802040A0BBAGAI
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 120microgram inj pre-filled pens CLEARCLICK
0802040A0BBAMAI
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 120microgram inj vials
0802040A0BBAEAE
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 150microgram inj pre-filled pens
0802040A0BBAFAH
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 150microgram inj pre-filled pens CLEARCLICK
0802040A0BBANAH
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 150microgram inj vials
0802040A0BBADAD
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 50microgram inj pre-filled pens
0802040A0BBAHAJ
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 50microgram inj pre-filled pens CLEARCLICK
0802040A0BBALAJ
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 50microgram inj vials
0802040A0BBACAC
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 80microgram inj pre-filled pens
0802040A0BBAJAL
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 80microgram inj pre-filled pens CLEARCLICK
0802040A0BBAKAL
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
ViraferonPeg 80microgram inj vials
0802040A0BBAAAA
|
ViraferonPeg | Peginterferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Vismodegib 150mg capsules
0801050BMAAAAAA
|
Vismodegib | Vismodegib | Malignant Disease and Immunosuppression | No data available |
|
Vivadex 0.5mg capsules
0802020T0BFACAF
|
Vivadex | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Vivadex 1mg capsules
0802020T0BFABAB
|
Vivadex | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Vivadex 5mg capsules
0802020T0BFAAAA
|
Vivadex | Tacrolimus | Malignant Disease and Immunosuppression | No data available |
|
Vizimpro 15mg tablets
0801050CQBBAAAA
|
Vizimpro | Dacomitinib | Malignant Disease and Immunosuppression | No data available |
|
Vizimpro 30mg tablets
0801050CQBBABAB
|
Vizimpro | Dacomitinib | Malignant Disease and Immunosuppression | No data available |
|
Vizimpro 45mg tablets
0801050CQBBACAC
|
Vizimpro | Dacomitinib | Malignant Disease and Immunosuppression | No data available |
|
Votrient 200mg tablets
0801050AZBBAAAA
|
Votrient | Pazopanib | Malignant Disease and Immunosuppression | No data available |
|
Votrient 400mg tablets
0801050AZBBABAB
|
Votrient | Pazopanib | Malignant Disease and Immunosuppression | No data available |
|
Votubia 10mg tablets
0801050AXBCACAB
|
Votubia | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Votubia 2.5mg tablets
0801050AXBCABAC
|
Votubia | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Votubia 2mg dispersible tablets
0801050AXBCADAG
|
Votubia | Everolimus | Malignant Disease and Immunosuppression | No data available |
|
Votubia 3mg dispersible tablets
0801050AXBCAEAH
|
Votubia | Everolimus | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.